Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Pape

Showing results (151-160 of 240) with videos related to

Pageof 24
Sort By:
Pediatric Nephrology (Berlin, Germany)|July 21, 2025
Association of intrapatient tacrolimus variability and concentration-to-dose ratio with outcomes in pediatric kidney transplantationMaral Baghai Arassi, Nora Fisch, Manuel Feißt, et al.
Frontiers in Nephrology|March 6, 2024
A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trialSinem Karaterzi, Burkhard Tönshoff, Thurid Ahlenstiel-Grunow, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 21, 2018
Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trialBurkhard Tönshoff, Robert Ettenger, Luca Dello Strologo, et al.
Clinical Kidney Journal|April 17, 2020
Relative incidence of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in clinically suspected cases of thrombotic microangiopathyUlf Schönermarck, Wolfgang Ries, Bernd Schröppel, et al.
Pediatric Nephrology (Berlin, Germany)|February 25, 2010
Urinary proteome analysis identifies infants but not older children requiring pyeloplastyJens Drube, Petra Zürbig, Eric Schiffer, et al.
Plos One|February 4, 2015
An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney diseaseTobias Eisenberger, Christian Decker, Milan Hiersche, et al.
Pediatric Nephrology (Berlin, Germany)|January 13, 2016
Febrile urinary tract infection after pediatric kidney transplantation: a multicenter, prospective observational studyFriederike Weigel, Anja Lemke, Burkhard Tönshoff, et al.
Proteomics. Clinical Applications|April 4, 2018
Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide HandlingPedro Magalhães, Claudia Pontillo, Martin Pejchinovski, et al.
Pediatric Nephrology (Berlin, Germany)|July 13, 2016
Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutationsJohanna Stock, Johannes Kuenanz, Niklas Glonke, et al.
Transplantation|December 11, 2012
Characteristics of early and late PTLD development in pediatric solid organ transplant recipientsTilmann Schober, Theodor Framke, Hans Kreipe, et al.
Pageof 24

Showing results (151-160 of 240) with videos related to

Sort By:
Pageof 24
Pediatric Nephrology (Berlin, Germany)|July 21, 2025
Association of intrapatient tacrolimus variability and concentration-to-dose ratio with outcomes in pediatric kidney transplantationMaral Baghai Arassi, Nora Fisch, Manuel Feißt, et al.
Frontiers in Nephrology|March 6, 2024
A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trialSinem Karaterzi, Burkhard Tönshoff, Thurid Ahlenstiel-Grunow, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 21, 2018
Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trialBurkhard Tönshoff, Robert Ettenger, Luca Dello Strologo, et al.
Clinical Kidney Journal|April 17, 2020
Relative incidence of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in clinically suspected cases of thrombotic microangiopathyUlf Schönermarck, Wolfgang Ries, Bernd Schröppel, et al.
Pediatric Nephrology (Berlin, Germany)|February 25, 2010
Urinary proteome analysis identifies infants but not older children requiring pyeloplastyJens Drube, Petra Zürbig, Eric Schiffer, et al.
Plos One|February 4, 2015
An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney diseaseTobias Eisenberger, Christian Decker, Milan Hiersche, et al.
Pediatric Nephrology (Berlin, Germany)|January 13, 2016
Febrile urinary tract infection after pediatric kidney transplantation: a multicenter, prospective observational studyFriederike Weigel, Anja Lemke, Burkhard Tönshoff, et al.
Proteomics. Clinical Applications|April 4, 2018
Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide HandlingPedro Magalhães, Claudia Pontillo, Martin Pejchinovski, et al.
Pediatric Nephrology (Berlin, Germany)|July 13, 2016
Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutationsJohanna Stock, Johannes Kuenanz, Niklas Glonke, et al.
Transplantation|December 11, 2012
Characteristics of early and late PTLD development in pediatric solid organ transplant recipientsTilmann Schober, Theodor Framke, Hans Kreipe, et al.
Pageof 24